The COVID-19 pandemic continues to affect healthcare delivery of HIV and HCV prevention and treatment. Clients may experience negative health outcomes due to limited or restricted access to antiretroviral therapy prescriptions, HIV primary care services, hepatitis C (HCV) clinical services, adherence counseling, PrEP, and other support services. Many providers are filling these gaps in care by implementing telehealth programs.

This two-hour virtual summit will provide information on the state of telehealth today by bringing together experts to highlight what is happening in the field and to share lessons learned from the COVID-19 pandemic. The summit will break out into three concurrent sessions with guest speakers to discuss key components of telehealth implementation: technology infrastructure for telehealth, client engagement in telehealth, and strategies for provider readiness.

SUMMIT AGENDA

2:00 PM – State of Telehealth and Implications for HIV Prevention, Care & Treatment

• Brian Hujdich – Executive Director at HealthHIV

• Circe Le Compte, PhD – Director of Health Services Research & Evaluation at HealthHIV

• Emily Yoder – Analyst at Centers for Medicare & Medicaid Services

• Reetu Grewal, MD – Medical Director at UF Health Family Medicine & Pediatrics Baymeadows

3:00 – 4:00 PM – Breakout Sessions

Technology for Telehealth

• Madhuri Lad, DO, FACOI, AAHIVS – Assistant Medical Director at Oklahoma State University Ryan White HIV Clinic

• Michael Snyder, MD, PhD, FACS – Professor and Chair of Genetics at Stanford University School of Medicine
  

Promoting Client Engagement in TelePrEP

• Tristan Schukraft, President & CEO, MISTR

• Daniel Soto, Telehealth Coordinator, REACH LA

• Megan Brunson – COO, Texas Health Action
  

Increasing Provider Readiness for Telehealth Provision

• Michael Murphree, LICSW – Chief Executive Officer at Medical Advocacy and Outreach

• Nicki Perisho, BA, BSN, RN – Program Director, Northwest Regional Telehealth Resource Center